CEPI (Coalition for Epidemic Preparedness Innovations) is not a venture capital firm in the traditional sense. It is a global organization launched to accelerate the development of vaccines and other biologic countermeasures against epidemic and pandemic threats, ensuring equitable access to these countermeasures for all people in need. CEPI operates as a funding and coordinating body, bringing together public, private, and academic partners to address gaps in vaccine development and deployment. Its strategy focuses on identifying and supporting promising vaccine candidates and platform technologies against emerging viral threats, with a particular emphasis on the 100 Days Mission, which aims to develop and deploy new vaccines within 100 days of identifying a new pathogen. A core tenet of CEPI's approach is equitable access, ensuring that vaccines developed with its support are available to all populations, regardless of their economic status or geographic location. CEPI fills a crucial role in addressing global health security by coordinating research, development, and manufacturing efforts to respond rapidly and effectively to future pandemics.
Preferred startup development maturity for initial funding deployment.
Vaccine development, biologics, epidemic preparedness, pandemic response, emerging viral threats, platform technologies
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...